Chronic Kidney Disease On Dialysis

• CLINICAL_TRIALS trial_result · 2021-06-02
  Clinical Trial Update: PA21 Safety and Efficacy in Adult Chinese Subjects [Phase 3]

  Phase 3 clinical trial update evaluating PA21 safety and efficacy in adult Chinese subjects with chronic kidney disease on dialysis and hype…

• FDA approval · 2020-08-11
  FDA Approved: SEVELAMER CARBONATE — Original Application (Zydus Lifesciences Limited)

  FDA approved the original application for Sevelamer carbonate by Zydus Lifesciences Limited.

• FDA approval · 2020-03-25
  FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for Sevelamer Carbonate from Aurobindo Pharma Limited, enabling its continued/expanded generic use.

• FDA approval · 2019-05-21
  FDA Approved: PARICALCITOL — Supplemental Application (Amneal Pharmaceuticals LLC)

  The FDA approved a supplemental application for PARICALCITOL from Amneal Pharmaceuticals LLC. This action concerns the generic PARICALCITOL …